Why Is Owens & Minor, Inc. (OMI) Under Investigation?

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Owens & Minor, Inc. (“Owens & Minor” or “the Company”) (NYSE: OMI). Investors who purchased Owens & Minor securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Owens & Minor has violated federal securities laws.

What Potential Securities Violations Is BG&G Investigating?

On February 3, 2024, Owens & Minor issued a press release “announc[ing] selected preliminary financial results for the fourth quarter and year ended December 31, 2024 in advance of its upcoming earnings announcement and conference call.” Among other items, Owens & Minor reported revenue that fell short of consensus estimates and said that it “expects to record a non-cash goodwill impairment charge within its Apria division of approximately $310 million, or approximately ($4.00) net loss per share.” The Company attributed the impairment charge “to a combination of factors occurring in the fourth quarter 2024”, “[t]he majority of [which] are related to financial market changes inclusive of a decline in Owens & Minor’s stock price and rising interest rates.” On this news, Owens & Minor’s stock price fell $5.01 per share, or 35.18%, to close at $9.23 per share on February 3, 2025.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Owens & Minor securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660